A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasm
Interventions: DRUG: 9-cis-Retinoic Acid
Sponsor: National Cancer Institute (NCI)